The role of real-world studies in the management of non-center-involving diabetic macular edema.
作者信息
Mishra Chitaranjan, Mohanty Nabatika
机构信息
Department of Vitreo-Retina Services, Trilochan Netralaya, Budharaja, Sambalpur, Odisha, India.
出版信息
Indian J Ophthalmol. 2024 Feb 1;72(2):289-290. doi: 10.4103/IJO.IJO_1411_23. Epub 2024 Jan 25.
Abstract
摘要
相似文献
1
The role of real-world studies in the management of non-center-involving diabetic macular edema.真实世界研究在非累及中心的糖尿病性黄斑水肿管理中的作用
Indian J Ophthalmol. 2024 Feb 1;72(2):289-290. doi: 10.4103/IJO.IJO_1411_23. Epub 2024 Jan 25.
2
Real-world clinical insights and aqueous humor biomarker analysis of diabetic macular edema subtypes classified by OCT following intravitreal injections.玻璃体内注射后，根据光学相干断层扫描（OCT）分类的糖尿病性黄斑水肿亚型的真实世界临床见解及房水生物标志物分析
BMC Ophthalmol. 2025 Jul 1;25(1):374. doi: 10.1186/s12886-025-04186-6.
3
Ranibizumab in Diabetic Retinopathy with or without Diabetic Macular Edema.雷珠单抗治疗伴或不伴糖尿病性黄斑水肿的糖尿病视网膜病变
Ophthalmol Retina. 2020 Oct;4(10):1034-1036. doi: 10.1016/j.oret.2020.05.020. Epub 2020 Jun 5.
4
Retinopathy Regression with Treat and Extend Ranibizumab for Diabetic Macular Edema.雷珠单抗治疗并延长给药方案用于糖尿病性黄斑水肿的视网膜病变消退情况
Ophthalmology. 2018 Aug;125(8):1304-1306. doi: 10.1016/j.ophtha.2018.03.046. Epub 2018 May 3.
5
Hispanic Ethnicity and Optical Coherence Tomography-based Biomarkers as Predictive Factors of Diabetic Macular Edema Refractory to Bevacizumab.西班牙裔种族与基于光学相干断层扫描的生物标志物作为贝伐单抗难治性糖尿病性黄斑水肿的预测因素
Ophthalmic Surg Lasers Imaging Retina. 2025 Jun;56(6):346-353. doi: 10.3928/23258160-20250127-02. Epub 2025 Mar 1.
6
Effect of intravitreal ranibizumab on serous retinal detachment in diabetic macular edema.
J Diabetes Complications. 2022 Jul;36(7):108228. doi: 10.1016/j.jdiacomp.2022.108228. Epub 2022 Jun 7.
7
Ensemble machine learning algorithm for anti-VEGF treatment efficacy prediction in diabetic macular edema.用于预测糖尿病性黄斑水肿抗VEGF治疗疗效的集成机器学习算法
BMC Ophthalmol. 2025 Jul 1;25(1):352. doi: 10.1186/s12886-025-04181-x.
8
Association between the patterns of diabetic macular edema and photoreceptors' response after intravitreal ranibizumab treatment: a spectral-domain optical coherence tomography study.脉络膜新生血管性糖尿病黄斑水肿的类型与玻璃体内注射雷珠单抗治疗后光感受器反应的相关性：频域光相干断层扫描研究。
Int Ophthalmol. 2020 Oct;40(10):2441-2448. doi: 10.1007/s10792-020-01423-3. Epub 2020 May 18.
9
SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY BIOMARKERS OF RETINAL HYPERPERMEABILITY AND CHOROIDAL INFLAMMATION AS PREDICTORS OF SHORT-TERM FUNCTIONAL AND ANATOMICAL OUTCOMES IN EYES WITH DIABETIC MACULAR EDEMA TREATED WITH INTRAVITREAL BEVACIZUMAB.频域光相干断层扫描生物标志物在预测糖尿病黄斑水肿患者接受玻璃体内贝伐单抗治疗后的短期功能和解剖结局中的作用：视网膜高通透性和脉络膜炎症的预测因子。
Retina. 2022 Apr 1;42(4):760-766. doi: 10.1097/IAE.0000000000003361.
10
Macular Hole Formation after Intravitreal Injection of Bevacizumab for Diabetic Macular Edema.玻璃体内注射贝伐单抗治疗糖尿病性黄斑水肿后黄斑裂孔的形成
Korean J Ophthalmol. 2019 Apr;33(2):198-199. doi: 10.3341/kjo.2018.0079.
本文引用的文献
1
Natural course of non-center-involving diabetic macular edema progression in patients under initial observation.初次观察的非中心累及性糖尿病性黄斑水肿患者的自然病程
Indian J Ophthalmol. 2024 Feb 1;72(2):236-239. doi: 10.4103/IJO.IJO_2182_22. Epub 2023 Dec 26.
2
Diabetic macular edema treatment guidelines in India: All India Ophthalmological Society Diabetic Retinopathy Task Force and Vitreoretinal Society of India consensus statement.印度糖尿病性黄斑水肿治疗指南：全印度眼科协会糖尿病视网膜病变工作组和印度玻璃体视网膜学会共识声明。
Indian J Ophthalmol. 2021 Nov;69(11):3076-3086. doi: 10.4103/ijo.IJO_1469_21.
3
Should we still be performing macular laser for non-centre involving diabetic macular oedema? Yes.对于非累及黄斑中心的糖尿病性黄斑水肿，我们仍应进行黄斑激光治疗吗？答案是肯定的。
Eye (Lond). 2022 Mar;36(3):483-484. doi: 10.1038/s41433-021-01793-7. Epub 2021 Oct 13.
4
Should we still be performing macular laser for non-centre involving diabetic macular oedema? No.对于不涉及黄斑中心的糖尿病性黄斑水肿，我们还应该进行黄斑激光治疗吗？不应该。
Eye (Lond). 2022 Mar;36(3):485-486. doi: 10.1038/s41433-021-01787-5. Epub 2021 Oct 13.
5
Real-world outcomes of observation and treatment in diabetic macular edema with very good visual acuity: the OBTAIN study.现实世界中视力较好的糖尿病性黄斑水肿的观察和治疗结果：OBTAIN 研究。
Acta Diabetol. 2019 Jul;56(7):777-784. doi: 10.1007/s00592-019-01310-z. Epub 2019 Mar 22.
6
Interpretation and Impact of Real-World Clinical Data for the Practicing Clinician.真实世界临床数据对临床医生的解读和影响。
Adv Ther. 2018 Nov;35(11):1763-1774. doi: 10.1007/s12325-018-0805-y. Epub 2018 Oct 24.
7
Guidelines on Diabetic Eye Care: The International Council of Ophthalmology Recommendations for Screening, Follow-up, Referral, and Treatment Based on Resource Settings.糖尿病眼病护理指南：国际眼科理事会基于资源设置的筛查、随访、转诊和治疗建议。
Ophthalmology. 2018 Oct;125(10):1608-1622. doi: 10.1016/j.ophtha.2018.04.007. Epub 2018 May 24.
8
Photobiomodulation in the treatment of patients with non-center-involving diabetic macular oedema.光生物调节治疗非中心性累及的糖尿病黄斑水肿。
Br J Ophthalmol. 2014 Aug;98(8):1013-5. doi: 10.1136/bjophthalmol-2013-304477. Epub 2014 Mar 28.
9
Effectiveness of laser photocoagulation in clinically significant macular edema with focal versus diffuse parafoveal thickening on optical coherence tomography.光学相干断层扫描显示局灶性与弥漫性黄斑中心凹旁增厚的临床显著性黄斑水肿中激光光凝的有效性。
Ophthalmic Surg Lasers Imaging. 2009 Sep-Oct;40(5):472-9. doi: 10.3928/15428877-20090901-06.
10
Effect of focal/grid photocoagulation on visual acuity and retinal thickening in eyes with non-center-involved diabetic macular edema.局灶/格栅光凝对非累及中心凹的糖尿病性黄斑水肿患者视力及视网膜增厚的影响。
Retina. 2009 May;29(5):613-7. doi: 10.1097/IAE.0b013e3181a2c07a.
Zotero 插件